Concepts (173)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Dendritic Cells | 8 | 2018 | 1085 | 0.390 |
Why?
|
| Cancer Vaccines | 6 | 2018 | 697 | 0.340 |
Why?
|
| Receptors, Antigen, T-Cell | 4 | 2023 | 1146 | 0.260 |
Why?
|
| T-Lymphocytes | 8 | 2023 | 3869 | 0.240 |
Why?
|
| Immunotherapy, Adoptive | 4 | 2019 | 1763 | 0.210 |
Why?
|
| Epstein-Barr Virus Infections | 2 | 2023 | 489 | 0.190 |
Why?
|
| Antigen Presentation | 4 | 2011 | 272 | 0.180 |
Why?
|
| Killer Cells, Natural | 3 | 2016 | 904 | 0.180 |
Why?
|
| Cysteine Endopeptidases | 2 | 2011 | 251 | 0.160 |
Why?
|
| Antigens, CD19 | 2 | 2019 | 577 | 0.160 |
Why?
|
| Adenoviridae | 5 | 2019 | 1459 | 0.150 |
Why?
|
| Transduction, Genetic | 2 | 2016 | 475 | 0.150 |
Why?
|
| CD28 Antigens | 1 | 2017 | 202 | 0.140 |
Why?
|
| CD3 Complex | 1 | 2017 | 314 | 0.140 |
Why?
|
| T-Lymphocyte Subsets | 2 | 2017 | 582 | 0.140 |
Why?
|
| K562 Cells | 2 | 2016 | 338 | 0.140 |
Why?
|
| Cell Culture Techniques | 2 | 2016 | 598 | 0.130 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2 | 2019 | 2796 | 0.130 |
Why?
|
| Lymphoma | 1 | 2023 | 1467 | 0.130 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 2 | 2011 | 1265 | 0.110 |
Why?
|
| Histocompatibility Antigens Class II | 2 | 2003 | 182 | 0.110 |
Why?
|
| Lymphoma, B-Cell | 1 | 2019 | 895 | 0.110 |
Why?
|
| Transgenes | 2 | 2013 | 557 | 0.110 |
Why?
|
| Genetic Vectors | 5 | 2019 | 1694 | 0.100 |
Why?
|
| Receptors, Antigen | 1 | 2011 | 76 | 0.100 |
Why?
|
| Interleukin-7 | 2 | 2023 | 95 | 0.090 |
Why?
|
| Herpesvirus 4, Human | 3 | 2023 | 966 | 0.090 |
Why?
|
| Oncolytic Viruses | 2 | 2009 | 204 | 0.090 |
Why?
|
| Flow Cytometry | 6 | 2017 | 3033 | 0.090 |
Why?
|
| HIV | 1 | 2011 | 229 | 0.090 |
Why?
|
| Th1 Cells | 1 | 2010 | 250 | 0.090 |
Why?
|
| Vaccines, DNA | 1 | 2009 | 105 | 0.080 |
Why?
|
| HSP70 Heat-Shock Proteins | 1 | 2009 | 161 | 0.080 |
Why?
|
| Chemokine CCL5 | 1 | 2009 | 71 | 0.080 |
Why?
|
| Immunity | 1 | 2011 | 342 | 0.080 |
Why?
|
| Antigens, Neoplasm | 2 | 2018 | 1506 | 0.080 |
Why?
|
| T-Lymphocytes, Cytotoxic | 2 | 2011 | 1016 | 0.080 |
Why?
|
| Viral Vaccines | 1 | 2010 | 304 | 0.080 |
Why?
|
| T-Lymphocytes, Regulatory | 2 | 2011 | 673 | 0.080 |
Why?
|
| Lymphocyte Activation | 3 | 2017 | 1688 | 0.070 |
Why?
|
| HIV Envelope Protein gp120 | 1 | 2006 | 62 | 0.070 |
Why?
|
| HIV Infections | 2 | 2011 | 2134 | 0.070 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2011 | 1555 | 0.070 |
Why?
|
| AIDS Vaccines | 1 | 2006 | 78 | 0.070 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 4 | 2011 | 1489 | 0.070 |
Why?
|
| Nerve Tissue Proteins | 1 | 2013 | 1491 | 0.060 |
Why?
|
| Mice | 12 | 2023 | 34495 | 0.060 |
Why?
|
| Blood Component Removal | 2 | 2016 | 121 | 0.060 |
Why?
|
| Glutamate Carboxypeptidase II | 1 | 2003 | 15 | 0.060 |
Why?
|
| Interleukin-15 | 2 | 2017 | 185 | 0.060 |
Why?
|
| Mice, Transgenic | 5 | 2011 | 4143 | 0.060 |
Why?
|
| Cytokines | 3 | 2023 | 2809 | 0.060 |
Why?
|
| Antigens, Surface | 1 | 2003 | 295 | 0.050 |
Why?
|
| Epitopes, T-Lymphocyte | 1 | 2003 | 219 | 0.050 |
Why?
|
| Immunotherapy | 3 | 2011 | 3341 | 0.050 |
Why?
|
| Heat-Shock Proteins | 1 | 2003 | 311 | 0.050 |
Why?
|
| Adjuvants, Immunologic | 1 | 2006 | 657 | 0.050 |
Why?
|
| Receptor, ErbB-2 | 1 | 2011 | 2518 | 0.050 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2009 | 1586 | 0.050 |
Why?
|
| Animals | 12 | 2023 | 59536 | 0.050 |
Why?
|
| HIV-1 | 1 | 2006 | 653 | 0.050 |
Why?
|
| Mice, Inbred C57BL | 5 | 2011 | 6942 | 0.050 |
Why?
|
| Telomerase | 1 | 2003 | 525 | 0.050 |
Why?
|
| Cell Line | 4 | 2010 | 5114 | 0.050 |
Why?
|
| Tumor Necrosis Factor alpha-Induced Protein 3 | 2 | 2011 | 16 | 0.040 |
Why?
|
| Ovalbumin | 2 | 2010 | 254 | 0.040 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2018 | 10035 | 0.040 |
Why?
|
| Vaccination | 1 | 2006 | 1123 | 0.040 |
Why?
|
| Retroviridae | 1 | 2019 | 332 | 0.040 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2018 | 6915 | 0.040 |
Why?
|
| RNA, Small Interfering | 3 | 2010 | 2216 | 0.040 |
Why?
|
| Cell Engineering | 1 | 2018 | 37 | 0.040 |
Why?
|
| Neoplasm Proteins | 1 | 2009 | 3230 | 0.040 |
Why?
|
| Lymphocyte Transfusion | 1 | 2018 | 175 | 0.040 |
Why?
|
| Cell Differentiation | 3 | 2017 | 4078 | 0.040 |
Why?
|
| Leukocyte Common Antigens | 1 | 2017 | 188 | 0.040 |
Why?
|
| Antigens | 2 | 2010 | 292 | 0.040 |
Why?
|
| Gene Silencing | 2 | 2011 | 837 | 0.040 |
Why?
|
| Feeder Cells | 1 | 2016 | 13 | 0.030 |
Why?
|
| Interleukin-12 | 2 | 2009 | 253 | 0.030 |
Why?
|
| Cell Transplantation | 1 | 2016 | 85 | 0.030 |
Why?
|
| Cells, Cultured | 3 | 2013 | 5637 | 0.030 |
Why?
|
| Melanoma, Experimental | 2 | 2010 | 368 | 0.030 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 2017 | 675 | 0.030 |
Why?
|
| Neoplasms | 3 | 2009 | 15193 | 0.030 |
Why?
|
| Brain Neoplasms | 1 | 2011 | 4849 | 0.030 |
Why?
|
| Humans | 12 | 2023 | 261506 | 0.030 |
Why?
|
| Interleukin-2 | 1 | 2017 | 842 | 0.030 |
Why?
|
| Transplantation, Autologous | 1 | 2018 | 1914 | 0.030 |
Why?
|
| 4-1BB Ligand | 1 | 2012 | 15 | 0.030 |
Why?
|
| Tumor Microenvironment | 1 | 2023 | 2864 | 0.030 |
Why?
|
| Immunophenotyping | 1 | 2017 | 1681 | 0.030 |
Why?
|
| Cell Line, Tumor | 4 | 2011 | 14551 | 0.030 |
Why?
|
| Cryopreservation | 1 | 2012 | 175 | 0.030 |
Why?
|
| Cell Separation | 2 | 2003 | 612 | 0.030 |
Why?
|
| DNA Transposable Elements | 1 | 2013 | 222 | 0.020 |
Why?
|
| Chemokine CCL21 | 1 | 2011 | 4 | 0.020 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 2012 | 235 | 0.020 |
Why?
|
| Receptors, CCR | 1 | 2011 | 4 | 0.020 |
Why?
|
| Receptors, CCR7 | 1 | 2011 | 39 | 0.020 |
Why?
|
| Epitopes | 2 | 2003 | 685 | 0.020 |
Why?
|
| Flagellin | 1 | 2010 | 28 | 0.020 |
Why?
|
| Green Fluorescent Proteins | 1 | 2013 | 694 | 0.020 |
Why?
|
| Immunization, Secondary | 1 | 2010 | 110 | 0.020 |
Why?
|
| Hydroxamic Acids | 1 | 2013 | 442 | 0.020 |
Why?
|
| Cell Proliferation | 2 | 2016 | 7226 | 0.020 |
Why?
|
| Young Adult | 2 | 2019 | 21445 | 0.020 |
Why?
|
| Coculture Techniques | 1 | 2011 | 626 | 0.020 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2013 | 709 | 0.020 |
Why?
|
| beta-Defensins | 1 | 2009 | 30 | 0.020 |
Why?
|
| Adenovirus E1B Proteins | 1 | 2009 | 22 | 0.020 |
Why?
|
| Cell Division | 2 | 2003 | 2489 | 0.020 |
Why?
|
| Vaccines, Synthetic | 1 | 2010 | 355 | 0.020 |
Why?
|
| Mice, Inbred NOD | 1 | 2011 | 905 | 0.020 |
Why?
|
| COS Cells | 1 | 2009 | 377 | 0.020 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2013 | 612 | 0.020 |
Why?
|
| Adaptive Immunity | 1 | 2009 | 149 | 0.020 |
Why?
|
| CD4-Positive T-Lymphocytes | 2 | 2003 | 1033 | 0.020 |
Why?
|
| Immunoprecipitation | 1 | 2009 | 591 | 0.020 |
Why?
|
| Adolescent | 2 | 2019 | 31252 | 0.020 |
Why?
|
| Mice, Knockout | 2 | 2009 | 5710 | 0.020 |
Why?
|
| Transfection | 1 | 2013 | 2944 | 0.020 |
Why?
|
| Child | 2 | 2019 | 29154 | 0.020 |
Why?
|
| Peptides | 2 | 2003 | 1479 | 0.020 |
Why?
|
| Mice, Inbred Strains | 1 | 2008 | 521 | 0.020 |
Why?
|
| Alleles | 2 | 2003 | 2437 | 0.020 |
Why?
|
| Mice, SCID | 1 | 2011 | 1869 | 0.020 |
Why?
|
| Graft vs Host Disease | 1 | 2018 | 2638 | 0.020 |
Why?
|
| Azacitidine | 1 | 2013 | 1149 | 0.020 |
Why?
|
| Receptors, Interleukin-12 | 1 | 2006 | 12 | 0.020 |
Why?
|
| Suppressor of Cytokine Signaling 1 Protein | 1 | 2006 | 18 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2018 | 9180 | 0.020 |
Why?
|
| Suppressor of Cytokine Signaling Proteins | 1 | 2006 | 60 | 0.020 |
Why?
|
| Cell Survival | 1 | 2012 | 3045 | 0.020 |
Why?
|
| Oncolytic Virotherapy | 1 | 2009 | 280 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2003 | 4938 | 0.020 |
Why?
|
| Immunity, Innate | 1 | 2009 | 677 | 0.020 |
Why?
|
| Antibody Formation | 1 | 2006 | 383 | 0.020 |
Why?
|
| Interferon-gamma | 1 | 2009 | 1144 | 0.020 |
Why?
|
| Gene Expression | 1 | 2013 | 3570 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 1 | 2009 | 2314 | 0.020 |
Why?
|
| Peptide Biosynthesis | 1 | 2003 | 21 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 2011 | 5395 | 0.010 |
Why?
|
| HLA-DR Antigens | 1 | 2003 | 173 | 0.010 |
Why?
|
| Insecta | 1 | 2003 | 76 | 0.010 |
Why?
|
| Adoptive Transfer | 1 | 2006 | 446 | 0.010 |
Why?
|
| Adenoviruses, Human | 1 | 2003 | 181 | 0.010 |
Why?
|
| Blotting, Western | 1 | 2009 | 3536 | 0.010 |
Why?
|
| CD4 Antigens | 1 | 2003 | 170 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2019 | 16273 | 0.010 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 1 | 2008 | 992 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2018 | 14889 | 0.010 |
Why?
|
| Amino Acid Motifs | 1 | 2003 | 392 | 0.010 |
Why?
|
| RNA Interference | 1 | 2006 | 1408 | 0.010 |
Why?
|
| HLA Antigens | 1 | 2003 | 546 | 0.010 |
Why?
|
| Antibodies, Monoclonal | 2 | 2003 | 4367 | 0.010 |
Why?
|
| Male | 4 | 2018 | 123000 | 0.010 |
Why?
|
| Virus Replication | 1 | 2003 | 709 | 0.010 |
Why?
|
| B-Lymphocytes | 1 | 2006 | 1294 | 0.010 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2018 | 6550 | 0.010 |
Why?
|
| Female | 4 | 2018 | 141928 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2009 | 7548 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2003 | 2927 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2003 | 4233 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2018 | 32848 | 0.010 |
Why?
|
| Software | 1 | 2003 | 1321 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2003 | 6089 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2003 | 4971 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2003 | 6150 | 0.010 |
Why?
|
| Adult | 1 | 2018 | 77950 | 0.010 |
Why?
|
| Middle Aged | 1 | 2018 | 86204 | 0.010 |
Why?
|
| DNA-Binding Proteins | 1 | 2003 | 4821 | 0.010 |
Why?
|
| Antineoplastic Agents | 1 | 2013 | 14289 | 0.010 |
Why?
|